About us

Regenerative medicine, particularly gene and cell therapy, will allow us to replenish and heal our bodies. As we continue to harness the power of our biology, treatments will become cures.

Our mission is to provide next generation products, both as tools and treatments, that will allow regenerative medicine to realise its potential. Our proprietary TAOS and Intrastem technologies give Locate a unique opportunity to develop and enable the next generation of cellular and gene therapies.
Robin Quirk
Co-founder of Locate

Our strategy

We are currently developing a pipeline of products addressing unmet needs in orthopaedic applications. These have allowed us to optimise and validate our TAOS platform.

Treatment of Osteomyelitis

A TAOS based product for the natural healing of bone which contains a slow release antibiotic for the treatment of Osteomyelitis

Accelerated bone repair

A TAOS product containing a human growth factor for accelerated and pronounced bone repair and in particular, spinal fusions 

Stem cells for orthopaedic applications

A TAOS product containing stem cells for other orthopaedic applications.

Looking to the future

Locate is now seeking to broaden its applications of TAOS into non-orthopaedic applications, such as in the CNS, cardiovascular and other important tissues and organs.

In parallel, we are currently evaluating a number of development and partnership opportunities for Intrastem, our next generation transfection technology. This exciting technology has tremendous potential in the cell therapy and gene therapy applications.

Combining our TAOS and Intrastem to technologies provides Locate with the ability to create an optimal environment and to direct the therapeutic effects of cells, both endogenous and implanted, to provide powerful renegerative medicine opportunities.